Shire PLC (SHP.L)

SHP.L on London Stock Exchange

4,870.00GBp
11 Jul 2014
Price Change (% chg)

270.00p (+5.87%)
Prev Close
4,600.00p
Open
4,596.00p
Day's High
4,870.00p
Day's Low
4,577.00p
Volume
3,201,761
Avg. Vol
2,606,922
52-wk High
4,925.00p
52-wk Low
2,116.96p

SHP.L

Chart for SHP.L

About

Shire plc (Shire) is a specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), gastrointestinal (GI) diseases, human genetic therapies (HGT) and regenerative medicine (RM), as well as opportunities in... (more)

Overall

Beta: 0.69
Market Cap (Mil.): £28,715.00
Shares Outstanding (Mil.): 589.33
Dividend: 10.21
Yield (%): --

Financials

  SHP.L Industry Sector
P/E (TTM): 30.78 35.37 35.77
EPS (TTM): 1.58 -- --
ROI: 22.27 19.00 18.27
ROE: 34.11 19.78 19.16
Search Stocks

Shire seeks AbbVie bid of close to 53 pounds per share: sources

NEW YORK - Shire Plc is seeking a higher takeover offer from U.S. drugmaker AbbVie Inc that would value the company at about 31 billion pounds ($53 billion), according to people familiar with the matter.

12 Jul 2014

Shire seeks AbbVie bid of close to 53 pounds per share -sources

NEW YORK, July 12 - Shire Plc is seeking a higher takeover offer from U.S. drugmaker AbbVie Inc that would value the company at about 31 billion pounds ($53 billion), according to people familiar with the matter.

12 Jul 2014

Shire confirms in talks with AbbVie on takeover bid

- Shire Plc on Friday confirmed it has held a meeting with U.S. drugmaker AbbVie Inc to discuss AbbVie's takeover bid for the Dublin-based maker of drugs for rare diseases.

11 Jul 2014

UPDATE 1-Shire confirms in talks with AbbVie on takeover bid

July 11 - Shire Plc on Friday confirmed it has held a meeting with U.S. drugmaker AbbVie Inc to discuss AbbVie's takeover bid for the Dublin-based maker of drugs for rare diseases.

11 Jul 2014

Shire confirms in talks with AbbVie on takeover bid

July 11 - Shire Plc on Friday confirmed it has held a meeting with U.S. drugmaker AbbVie Inc to discuss AbbVie's takeover bid for the Dublin-based maker of drugs for rare diseases.

11 Jul 2014

Gains in Shire and tobacco stocks help end FTSE's losing streak

LONDON, July 11 - Britain's top equity index rose on Friday, propped up by gains in tobacco shares and healthcare stock Shire, breaking a four-day losing streak that saw it suffer its biggest weekly fall in three months.

11 Jul 2014

As Shire stays silent, some investors urge talks with AbbVie

LONDON - Some top investors in Shire are urging it to engage with AbbVie to discuss the U.S. drugmaker's $51 billion takeover bid as a prolonged silence from the London-listed drugmaker adds to uncertainty over a possible deal.

11 Jul 2014

CORRECTED-As Shire stays silent, some investors urge talks with AbbVie

* Other investors write to Shire board pushing case for deal

11 Jul 2014

AbbVie forced to retract claims of Shire investor support

LONDON - U.S. drugmaker AbbVie has been forced to retract comments by its chief executive about shareholder support for its $51 billion bid for Shire after being caught out by British takeover rules.

09 Jul 2014

UPDATE 2-AbbVie forced to retract claims of Shire investor support

* UK rules require written statements to make such claims

09 Jul 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Wright Reports
$75.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Ford Investor Services, Inc.
$12.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks